Search results
Drug-eluting Balloon Analysis
Author(s):
Alexander Ruebben
,
Juergen Boeing
,
Norbert Weiss
Added:
3 years ago
Article
Drug-eluting Balloon Analysis
Author(s):
Alexander Ruebben
,
Juergen Boeing
,
Norbert Weiss
Added:
3 years ago
Article
Author(s):
Ferry van der Linde
Added:
3 years ago
Recently, a novel type of interventional device has become available on the market: the drug-eluting balloon (DEB). The established performance of the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter has been combined with the proven efficacy of antiproliferative drugs.
The usefulness of DEBs has been established,1–6 especially for treating in-stent restenosis (ISR), when…
View more
Konstantinos Stavroulakis
Job title: Consultant of vascular and endovascular surgery
Author
Jason Wilkins
Job title: Consultant Interventional Radiologist
Author
Author(s):
Anouar Belkacemi
,
Pierfrancesco Agostoni
,
Michiel Voskuil
,
et al
Added:
3 years ago
In the past few decades, major progress has been made in the percutaneous treatment of coronary artery disease. Initially, the emergence of balloon angioplasty offered an alternative option for coronary revascularisation. However, abrupt closure and restenosis caused by elastic recoil, neointimal hyperplasia and late remodelling were major drawbacks of balloon angioplasty.1 The use of drug…
View more
Author(s):
Upul Wickramarachchi
,
Simon Eccleshall
Added:
3 years ago
Percutaneous coronary interventional techniques and devices have evolved enormously since Gruntzig performed his first coronary angioplasty in 1977. 1 It is now the norm to treat patients with both acute coronary syndrome and stable coronary artery disease with drug-eluting stents. We intend to review the evidence and discuss potential benefits of drug-coated balloon-only angioplasty. These…
View more
TCT 23: AGENT IDE
Author(s):
Robert Yeh
Added:
5 months ago
Video
Author(s):
Praveen Chandra
Added:
1 year ago
In this short interview, Dr Praveen Chandra (Medanta - The Medicity, IN) shares key findings from the study that looked at the sirolimus-coated balloon with micro-reservoir technology in coronary lesions. The study investigated the SELUTION SLR drug-eluting balloon (MedAlliance) for coronary and peripheral indications.
Discussion Points:
1. Study Rationale
2. Micro-reservoir Technology
3. Study…
View more
Author(s):
Raban Jeger
,
Thomas Nestelberger
Added:
3 years ago
Coronary artery disease (CAD) remains a major cause of morbidity and mortality despite major improvements in primary and secondary prevention strategies. Percutaneous coronary intervention (PCI) or surgical revascularisation may be indicated in many patients with acute or stable CAD.1
Since the first coronary intervention using catheter mounted balloons, percutaneous treatment of CAD has evolved…
View more